Mechanism of pulmonary endothelial cell heterogeneity and its role in disease
Mechanism of pulmonary endothelial cell heterogeneity and its role in disease
批准号:
10852353
负责人:
Lisandra Vila Ellis
金额:
$24.9万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-01 至 2026-08-31
关键词:
ATAC-seqAddressAdultAffectAlveolarAlveolusAppearanceBiologyBlood VesselsBlood capillariesBreedingBronchopulmonary DysplasiaCancer CenterCapillary Endothelial CellCell MaturationCellsCongenital alveolar dysplasiaDNADataDefectDevelopmentDevelopmental BiologyDiseaseEmbryoEndothelial CellsEndotheliumEnsureEpithelial CellsEpitheliumFOXF1 geneFailureFamilyFutureGasesGenesGeneticGenetic ModelsGenetic TranscriptionGenomicsHeterogeneityHumanHyperoxiaIndividualInterruptionLinkLocationLungLung diseasesMentorsMesenchymalModelingMorphologyMusMyofibroblastNamesNeonatal Hyperoxic InjuryPaperPhasePhenotypePhysiciansPhysiologicalPlayPopulationPostdoctoral FellowPredispositionPremature InfantProcessPublishingPulmonary alveolar structureResearchRetinaRoleSOX17 geneSamplingScientistSignal TransductionSpecific qualifier valueSurfaceTP53 geneTestingThree-Dimensional ImagingTimeTissuesTrainingVEGFA geneVascular SystemVirus DiseasesWorkcareercareer developmentcell fate specificationdevelopmental diseaseexperiencelung developmentmouse geneticsmouse modelmutantnovelpostnatalprotein expressionresponsesingle-cell RNA sequencingtranscription factorvascular abnormality
中文摘要
项目摘要/摘要
候选人:利桑德拉·维埃利斯博士是一位在血管生物学和肺发育方面接受过广泛培训的内科医生。
她是MD安德森癌症中心的博士后研究员,试图了解血管是如何发育的
以及这个过程在疾病中是如何受到影响的。她刚刚发表了她的第一篇论文,也是第一作者
发育细胞。
职业发展:Vila Ellis博士的导师包括陈继超博士,他是一位成功的科学家,研究
和伯顿·迪基博士,一位有30多年研究经验的内科医生
肺脏的经验。此外,Vila Ellis博士还将得到该领域许多合作者的支持
作为指导委员会,以确保她达到这项提案的预期里程碑,并保证
顺利过渡到独立职业生涯。
研究:Vila Ellis博士的工作表明,血管内皮生长因子A(Vegfa)指定了一种新的
肺内皮细胞的数量。这些细胞在转录和形态上是不同的,并且在
肺泡间隙异常增大,使人联想到支气管肺发育不良.在
未来,Vila Ellis博士将研究这种指定过程是如何发生的,以及这些新细胞在肺中扮演什么角色
疾病。
总之,这项建议将解决肺内皮细胞异质性的机制,并有助于
确立肺内皮细胞在发育性疾病起源中的关键成分。
英文摘要
PROJECT SUMMARY/ABSTRACT
Candidate: Dr. Lisandra Via Ellis is a physician with extensive training in vascular biology and lung development.
She is a postdoctoral fellow at MD Anderson Cancer Center seeking to understand how blood vessels develop
in the lung and how this process is affected in disease. She just published her first, first-author paper in
Developmental Cell.
Career development: Dr. Vila Ellis' mentors include Dr. Jichao Chen, a successful scientist who studies
developmental biology in the mouse lung, and Dr. Burton Dickey, a physician who has over 30 years of research
experience in the lung. Additionally, Dr. Vila Ellis will have the support of many collaborators in the field, as well
as a mentoring committee to ensure she meets the expected milestones of this proposal, and guarantee a
smooth transition to an independent career.
Research: Dr. Vila Ellis' work has shown that Vascular endothelial growth factor A (Vegfa) specifies a novel
population of endothelial cells in the lung. These cells are transcriptionally and morphologically distinct, and in
their absence the alveolar space is aberrantly enlarged, reminiscent of bronchopulmonary dysplasia. In the
future, Dr. Vila Ellis will study how this specification process happens and what role these new cells play in lung
disease.
In summary, this proposal will address the mechanisms of pulmonary endothelial cell heterogeneity and help
establish the lung endothelium as a key component in the origin of developmental diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism of pulmonary endothelial cell heterogeneity and its role in disease
-
批准号:10414872
-
项目类别:
-
资助金额:$10.45万
-
财政年份:2021
-
负责人:Lisandra Vila Ellis
-
依托单位:
海外基金